For private circulation amongst members only.www.ipga.in

NEWSLETTER OF INDIAN PHARMACY GRADUATES' ASSOCIATION

Special Issue 2020 RNI No. : DELENG/2013/51512

IPGA TODAYPANACEA 2020

From the Desk of President

S. L. Nasa

Mr. Ravi Uday Bhaskar

S. L. Sobti

Prof. (Dr.) G.N. Singh

Prof. (Dr.) R. K. Khar

Prof. (Dr.) S. S. Agrawal

Prof. (Dr.) M.D. BurandeProf. (Dr.) B.G. Shivananda

Prof. (Dr.) Dr. B. Suresh

S. W. DeshpandeProf. (Dr.) S. K. Kulkarni

Advisory Board

P. P. Sharma

Prof. (Dr.) Shahid Ansari

Mr. Shirish DabadeProf. (Dr.) Kamla Pathak

Prof. (Dr.) Javed Ali

Prof. (Dr.) Satyendra K Rajput

Ms. Zeba Khan

Prof. (Dr.) Vijay Bhalla

Editor in Chief

Ms. R. Mathangi

P. K. Jaggi

Editorial Board

Anil Kr. NegiDr.Arti R. Thakkar

Dr.Neerupma Dhiman

It is really tormenting to see the situation nowadays where the cases of the COVID-19 are increasing day by day all around the globe. More than Eighty nine lakh people have been affected and almost three lakh people have died across in over 200 countries. Although humanity is not witnessing such a pandemic for the first time earlier being Cholera, bubonic plague, smallpox, influenza, Spanish Flu to name a few but the present epidemic is also quite serious and deadly. The COVID-19 outbreak has created a lot of serious challenges to India's healthcare community. Many “New Normal” have been observed in various fields of Pharmacy profession and human life in general. We have observed that various colleges and universities have adopted online mode of education due to lockdown and hence helped in maintaining the social distancing. Similarly, many already existing pharmaceutical and cosmetics manufacturing firms have commenced manufacturing hand sanitizers just to fulfill the need of the present situation. It has been observed that many pharmaceutical companies are reinventing themselves to survive and even looking for new opportunities in terms of developing COVID-19 related diagnostic kits, high quality face masks, Personal Protection Equipment, affordable ventilators and interactive apps for delivering medications as well as tracking the COVID-19 patients. The current scenario has taught us that the Pharmaceutical Industry should be self-reliant, so that the API and other raw materials for the industry can be prepared in our own country and we need not rely on the other countries for their imports. The Central Government has already committed to support the Pharmaceutical Industry in more than one way If we are able to rise to the occasion then it will be the beginning of a new era for India's healthcare and pharmaceutical sector since India is already considered to be the Pharmacy of the world. Many safe and best practices have been proposed across India. The key points such as social distancing, wearing of mask, frequently washing our hands, resilience, hope and compassion for the deprived are considered to be the “New Normal” to keep the low rate of spread of the disease.

In this situation of distress and depression, IPGA had recently conducted the first online conclave which included the major areas related to the profession of Pharmacy ranging from Pharmaceutical Industry to IPR, to Research and Development and to Academia with the aim to boost the morale of the Pharmacy professionals belonging to different fields of Pharmacy. The IPGA student forum had also recently conducted an event named Panacea 2020 in collaboration with DIPSRU, in which the students of 29 Pharmacy colleges of Delhi NCR and 12 colleges outside Delhi NCR with an average footfall of 900 students had participated. The event was full of fun, sports, innovation and research activities. IPGA has initiated the IPGA-Women Forum for strengthening the Women Pharmacist in the profession. Lot of activities has been planned in that context too.

I am sure this issue of IPGA Today will provide you with the detailed information on the various professional activities of our association for the community and society we are living in. Stay Safe and Stay Healthy.

Editorial�Board

is Official NewsletterPublished & Produced by

Indian Pharmacy Graduates' AssociationF-2, A Block, DDA Shopping Complex,

Meera Bagh, New Delhi-110087

‘ The IPGA TODAY’

T DAYIPGA

Atul Kumar NasaPresident- IPGA

Managing Trustee- IPGA Welfare TrustVice President –AIDCOC

01

Inside :

Circulars 15-28

Scientific & New Drugs 29-30

Industry Updates 31-33

Seminar Report 34

Women's Forum Updates 35-36

Tribute to Padma Shree

Editor-in-Chief 02

Invited Articles 03-08

Student Activities 09-14

Gazette Notification and

From the Desk of President 01

From the Desk of

Prof. (Dr.)Harkrishan Singh 37-40

IPGA New Members 41-43

IPGA WELFARE TRUST 44

From the Desk of Editor-in-Chief

As the number of members of our Association increased, the idea of publication of IPGA TODAY was mooted way back in the early eighties with a view to convey information about the various activities of IPGA to all its members. It was published with a view to develop the faculties of practicing Pharmacists, keep them abreast with the recent advances in different fields of Pharmacy and also to improve their awareness. With the formation of IPGA WELFARE TRUST and the Students' Wing of IPGA, relevance of publishing IPGA TODAY increased manifold. Initially IPGA TODAY used to be printed and sent through post to all the members located in different parts of the country. Due to various factors IPGA TODAY now-a-days is hosted on the website of IPGA for quick dissemination of information to all its members in a digital format and also save on the scarce resources. I am confident that with the recent induction of young turks in its Editorial Board IPGA TODAY is bound to be better in design, content and usefulness.

Let us all pray and hope for an early break through to stop the ongoing pandemic for the sake of saving the human race.

Stay in, Stay Safe and Stay Strong. No doubt that 'Tough times don't last, Tough people do'.

My Greetings to all the members of IPGA family.

With no immediate signs of developing a vaccine against the Covid 19 virus, researchers in the Pharmaceutical and Health care Industry are already working overtime on the off-label use of various drugs including but not limited to Anti-Retroviral drugs like Remdesivir, Favipiravir, anti-malarial drugs like Hydroxychloroquine, Blood products for providing Plasma therapy and so on. The scientific and regulatory bodies in India like CSIR and DCGI are also putting in their extra efforts in clearance of research projects which are expected to lead to an early break through for an appropriate method of stopping the onslaught of Covid 19 virus.

To my belief Pharmacy as a subject, even as of date, provides very exciting opportunities in different fields ranging from Manufacturing, Analysis, Research, Sales and Distribution of Drugs and Pharmaceuticals apart from offering jobs in the field of Education and many other related fields. In the context of the present situation of COVID 19 pandemic all over the globe, the importance of Pharmacy as a subject has gained even more importance. With India having established itself as Pharmacy of the world, more avenues for Pharmacists in different sectors are opening up particularly in the field of research for newer drugs and Community Pharmacy. The Central Government has already announced several incentives for the rapid growth of the Pharmaceutical industry. With the changing environment of the health care more job opportunities for the Pharmacists are expected. However, it is imperative that there will be newer challenges and expectations of the co-health workers, patients as well Government bodies which, I am confident, in due course of time we will be able to overcome..

T DAYIPGA

PK JAGGIB Pharm LLB MBA

02

The pharmacy sector horizons are expanding,

mirroring the various developments impacting the

healthcare industry as a whole. This can widely be

attributed to the recent advancements of innovation

and technology. These changes have enabled the

pharmacist to take greater role and responsibilities

being a member of the patient's primary care team.

Advancements in healthcare technology continue to

lead innovations in retail and ambulatory pharmacy.

New health information technology (HIT) and the

increasing awareness and use of robotic dispensing

systems have made pharmacy operations faster and

more efficient, while at the same time improving

patient safety. Technology innovations have also led

to more streamlined and coordinated workflows,

which are helping pharmacies, optimize operations

throughout their entire drug delivery cycle.

The pharmaceutical industry is unique in several

ways in terms of the elaborate requirements for the

Health sector market. The pharmaceutical market

value is anticipated to grow approximately USD 1.1

trillion by 2021 globally. In this age of rapid

innovation in the technology, new opportunities and

fields are emerging continuously which are able to

provide better health care and management.

Integration of biotechnology and computer science

with pharmaceutical sector added great impact in

pharmaceutical research and development techniques

ranging from discovering new therapeutic molecules

on one end to providing patient customized treatment

which ultimately increases the patient outcome. This

article briefly describes latest techniques and

developments in Pharmaceutical and Biomedical

Research.

Increasing on-boarding of tech solutions is allowing

pharmacies to offset mounting economic realities,

which continue to shrink profit margins across all

pharmacy sectors. Automation solutions, which

include everything from robotic systems to integrated

workflow and pharmacy softwares, are enabling

pharmacies to re-prioritize resources. This allows

them to expand value-added offerings such as

telepharmacy services, long-term care, and mail

order, as well as improve efficiencies based on

centralized service models.

Figure 1: Expanding Horizons of the Pharmacy

Profession.

1. ARTIFICIAL INTELLIGENCE

Artificial Intelligence (AI) refers to utilisation of

computer systems or automated algorithm to perform

task which was previously dependent on human

intelligence. It saves human time, cost, effort and

provide better management and presentation of data.

Now a day's artificial intelligence tools are being used

at all the stages of drug discovery and development.

Artificial intelligence is also used in diagnosis of

disease by defining the effect of particular feature on

the disease, prediction of epidemic outbreaks as in

case of malaria, in distinguishing normal cells with

EXPANDING HORIZONS OF PHARMACY PROFESSIONShikha Baghel Chauhan, Vaishnavi Gupta

Amity Institute of Pharmacy, Amity University, Noida (U.P.) 201303

Invited Article

03

Nanotech-nology

ArtificialIntelligence

3D Printing

m Health Sensors

Organ-on-chip

Precision medicine

Drug discovery in the field of Oncology.

Drug discovery and synthesis

Oncology focussed health records

Breast cancer clinical trial

Analysis of Clinical trial operation

Personalised therapy for macular

degeneration and drug design

Prediction of dementia neurodegenerative

disease.

Development of Insilco drug discovery uit

Development of Biomedical medicine

Pfizer with IBM Watson

Pfizer with Massachusetts Institute of Technology

Roche with Flatiron Health

Novartis with IBM Watson

Novartis with McKinney’s

Novartis and Microsoft

Johnson and Johnson with Winter light Lab

Glaxo Smith Kline

Glaxo Smith Kline with Google

S.No. Company Year Purpose

2016

2018

2018

2017

2018

2019

2018

2019

2017

1

2

3

4

5

6

7

8

9

Invited Article

04

the cancerous cells. Artificial intelligence has

enormous role in pharmaceutical industry by making

everything streamlined by maintaining and analyzing

data and conducting repetitive task. Pharmaceutical

industry is adapting artificial intelligence in

collaboration with specialized artificial intelligence

driven companies and also by developing inner

expertise. Examples of Pharmaceutical Industry

using Artificial Intelligence are described in Table 1.

Table 1: Pharmaceutical Industry using Artificial Intelligence

2. PRECISION MEDICINE

These medicines consider individual patient

differences with the objective of right drug to the right

patient at the right time to improve the patient

condition and reduce the adverse effect associated

with it. As we all know that effect of any drug i.e. its

onset of action, absorption and metabolism is

different among us due to difference in individual

person at molecular and genetic level. Therefore,

precision medicine development can be defined as an

approach which combine the molecular and clinical

information to determine biological basis of disease.

In this technique, data is obtained from gene

sequencing and then this data is further used for

identification of gene abnormalities and effect of drug

in different patients. Few examples of Precision

Medicine are mentioned in Table 2.

Table 2: Precision Medicine

Chronic myeloid leukaemia

Lung Cancer

Breast Cancer

Colon cancer

Melanoma

BCR-ABL

ALK

HER-2/neuroreceptor

EFGR

BRAFV6006

S.No. Biomarker Drug name Disease condition

Gleevec

Xalkori

Herceptin

Erbitux

Zelboraf

1

2

3

4

5

Invited Article

05

5. m- HEALTH SENSORS

Smartphone have advanced processors and sensors

that can record information which are essential in the

post market studies and allow easy participation of

subjects in the studies. As more and more people

participate in such studies more data is collected and

that helps in producing more accurate result

enhancing better representation of the population.

Therefore, this technique has unique ability to engage

more people. It is not only limited to smart phones or

smart watches (Apple watch, Samsung gear) and

fitness bands. These sensors are capable of taking

biometric reading and are more advanced, accurate

and possess huge potential for collecting clinical trial

information in real world in real time settings. They

have sensors that can detect blood glucose,

temperature, heart rate, sleep, blood oxygen and

various other parameters. However, without internet

the information or data collected cannot be synced

with devices of researchers and doctors. m-Health

sensors are nowadays being used by pharmaceutical

industries in clinical research. m-Health sensors has

created shift in clinical research organizations

towards remote monitoring and reduced unnecessary

requirement of visiting hospital or research centre

during the clinical trial. Recently APPLE iPhone has

developed several applications for conducting

research on cardiovascular disease, diabetes and

asthma.

International Standard Organization (ISO) has

defined 3-D Printing as “fabrication of object through

rapid disposition of the material using printhead

nozzle or any other technology”. 3-D Printing is

basically manufacturing process which produces

three-dimensional solid dosage form by successive

addition of material layer by layer with the help of

computer aided model. This process allows delivery

of higher dosage of medicine up to 1000 mg and

produce porous pills which dissolve rapidly, thus,

providing better patient compliance. This technique is

gaining lot of importance due to rapid preparation and

can be utilized in developing novel dosage forms.

Some example of 3-D printed dosage form includes

implants, microneedles, orodispersable tablets,

floating and multicompartment tablets. Recently,

FDA approved first 3D printed epilepsy drug Spritam

by Aprecia Pharmaceuticals.

Organ-on-chip (OOC) is an alternative to traditional

testing and has solved various ethical issues

associated with preclinical studies. Generally, cell

line culture has semi-static conditions and doesn't

have the actual organ function, that's why prediction

of drug efficacy and toxicity became difficult.

Microchips lined by human cells are microfabricated

and are based on microfluidic device technology and

hence, can be used as novel organ model. They

actually mimic the function of different organs and a

3. 3-D PRINTING

Nanotechnology is one of the most rapidly growing

discipline in the pharmaceutical industry. It refers to

design, produce, characterize, structures or system

which are in nano size range from 1 to 100nm. These

are designed to deliver diagnostic and therapeutic

molecular substance across the biological barrier and

can detect small molecular changes. They overcome

several limitations of conventional dosage forms such

as low bioavailabity. From several examples Genexol

- PM by Samyang which is a lyophilized, sterile

polymeric micellar nanomedicine of paclitaxel for

breast cancer and small lung cancer.

Researchers are now developing a technology that

can track the medication after consumption. These

systems would provide information to physician and

are combination of nanotechnology and robotics

known as nanorobots taken in the form of pills and

injection and are effective against cancerous cells or

to perform surgical task.

6. Organ-on-chip

4. NANOTECHNOLOGY

Invited Article

06

1. Dayal P, (2018 Jul,24)16 Tech Advancements in

Pharmaceuticals to Reinvent healing.

http;//www.newsgenapps.com/blog/tech

advancements in pharmaceuticals to -re-invent

healing.

Conclusion:

2. Arsene C, (2019 May 4) Artificial Intelligence

& Pharma: What Next? http;//www.

Digitalauthority.me/resoures/artificial

intelligence-pharma/

It is pertinent to mention that pharmaceutical

industries are adopting digital technology to meet the

specific needs of their patients. It can be understood

that pharmaceutical industries nowadays not only

focus on selling the drug and medication but are also

concerned and inclined in adopting and implementing

latest technology and gadgets, thereby widening the

scope of the pharmacy profession.

References:

4. Jamroz W, 3-D printing in pharmaceutical and

medical applications- recent achievements and

challenges. Pharm Res..2018;35,(176);2-22

group of tissue like lung, liver, kidney, gut and

ultimately connect all systems building a whole-body

model. Ingber Research group had developed

“breathing lungs” having a two-layered channel

s t r u c t u r e s e p a r a t e d b y m i c r o p o r o u s

polydimethylsiloxane membrane (PDMS). They

have alveolar epithelial cells on the upper surface of

the membrane and vascular endothelial cell on the

lower membrane and also uses culture media and

flowing air to mimic lung structure and by managing

the internal and external pressure on both the sides,

thereby, maintaining the physiological contraction

and relaxation. The study proved that nanoparticles

uptake was increased when contraction movements in

the blood vessels were increased and similar results

were produced when similar study was conducted on

the rats.

5. Kimura H, Sakai Y, Fujji T; `Organ / body on a

chip based on microfluidic technology for drug

discovery.

Drug Metabolism and Pharmacokinetics;2018;

33:43-48

3. Kumar S, Emerging trends in pharmaceutical

sciences: An introduction to nanotechnology.

World journal of pharmaceutical

sciences.2014;12(2):1592-93

IT JUST TAKES FEW MINUTES

FOR YOU TO SAVE FOUR LIVES

07

Corona viruses (CoV) are a family of viruses that can

cause illnesses such as the common cold, severe acute

respiratory syndrome (SARS) and Middle East

respiratory syndrome (MERS). Corona viruses are

zoonotic, i.e. they are transmitted between animals

and humans. A novel corona virus (nCoV) is a new

strain that has not been identified in humans so far.

The virus is now known as the severe acute

respiratory syndrome corona virus 2 (SARS-CoV-2).

The disease it causes is called corona virus disease

2019 (COVID-19). The 2019 novel corona virus

(2019-nCoV; severe acute respiratory syndrome

corona virus 2 (SARS-CoV-2)) has spread rapidly

since its recent identification in patients with severe

pneumonia in Wuhan, China. As of 10th February

2020, 2019-nCoV has been reported in many

countries across different continents and >40,000

cases have been confirmed, with an estimated

mortality risk of ~2%. (2). WHO declared COVID 19

as global health emergency on 30th January 2020

followed by global pandemic on 11th March

2020.The data for the COVID 19 patient till 21st of

April stood at 2, 397 217 confirmed cases and 162 956

deaths and figures still rising unrelentleessly.

Characteristics of 2019-nCoV

2019-nCoV is an enveloped, positive-sense, single-

stranded RNA beta-corona virus. Similar to SARS

and MERS, the 2019-nCoV genome encodes non-

structural proteins (such as 3-chymotrypsin-like

protease, papain-like protease, helicase, and RNA-

dependent RNA polymerase), structural proteins

(such as spike glycoprotein) and accessory proteins (

Fig. 1) (1)

Invited Article

OVERVIEW ON COVID-19 Neerupma Dhiman1 and Arti Thakkar1

1Amity Institute of Pharmacy, Amity University Uttar Pradesh, Noida 201 313

Fig. 1

Invited Article

08

Symptoms

Unfortunately, no specific drug or vaccine has yet been approved to treat this human corona viruses. Initial analyses of genomic sequences from 2019-nCoV indicate that the catalytic sites of the four 2019-nCoV enzymes that could represent antiviral targets are highly conserved and share a high level of sequence similarity with the corresponding SARS and MERS enzymes. Furthermore, protein structural analyses suggest that key drug-binding pockets in viral enzymes are probably conserved across 2019-nCoV, SARS and MERS3. It is, therefore, reasonable to consider existing MERS and SARS inhibitors for 2019-nCoV.

However, new interventions are likely to require months or even years to develop to prove their worth. Given the urgency of the 2019-nCoV outbreak, the existing antiviral agents approved or in development for treating infections caused by HIV, hepatitis B virus (HBV), hepatitis C virus (HCV) and influenza, based on therapeutic experience with two other infections caused by human corona viruses: severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) are used(1) .

Who are at risk of this disease?

1) Nature Reviews Drug Discovery 19, 149-150 (2020)2) World Health Organization guidelines.

e) Avoid sharing dishes, glasses, bedding and otherhousehold items, if you're sick.

c) Stay away from the person who is showing the symptoms of the infection.

How Corona virus spreads

Human corona viruses most commonly spread from an infected person to others:a) By coughing and sneezingb) By touching or shaking handsc) Touching an object or surface contaminated with virus

Common signs of infection includes respiratory symptoms, fever, cough, shortness of breath and breathing difficulties. But in severe cases, the symptoms include pneumonia, severe acute respiratory syndrome, kidney failure and even death.

d) Avoiding the crowded places.

f) Clean and disinfect surfaces you often touch.

Currently there is no vaccine available to protect humans from corona virus but the prevention to this disease can be attained by reducing the transmission through:

g) Stay home from work, school and public areas, if you're sick.

a) Washing hands with warm water and soap or we can use alcohol based sanitizers.

h) Avoid eating raw or undercooked meat or animal organs.

Older people and those with pre-existing medical conditions (such as cardiovascular disease, chronic respiratory disease or diabetes) are comparatively at

greater risk for severe disease.

I) Avoid contact with live animals and surfaces they may have touched if you're visiting live markets in areas that have recently had new corona virus cases.

b) Avoiding touching eyes, nose and mouth with unwashed hands.

Treatment for COVID-19

Prevention

Several options can be envisaged to control or prevent emerging infections of 2019-nCoV, including vaccines, monoclonal antibodies, oligonucleotide-based therapies, peptides, interferon therapies and small-molecule drugs. Plasma therapy has also shown promising results in certain cases.

What to do if symptoms of infections are seen in any person in the family or in the neighborhood

Do not panic, call the emergency number for COVID in your area and they will take the person to the hospital with precaution and start the treatment. Infection with this disease does not necessarily results in death.

References:

With an immense amount of hard work and persistence that goes into organizing any event, we as an organization can stand tall and proud as we proclaim the success of this event which would have been nothing without the prodigious efforts of Shri Atul Kumar Nasa, President, IPGA along with the entire IPGA council team.

It was organized as a two day event on 29th February and 1st March 2020 at Delhi Pharmaceutical Sciences and Research University, New Delhi and was filled with jam packed scientific and academic events in juxtaposition with spectacular cultural competitions all of which gained momentum with a tremendous amount of participation from students all across the nation, coming together to celebrate a fest like no other.

Panacea saw an overwhelming response from 29 colleges of Delhi NCR and 12 colleges outside Delhi NCR with an average footfall of 900 students. It also included the participation of the IPGA Student Forum-Bihar Chapter.

PANACEA - India's First Pharma Fest which encompassed the entire Pharmaceutical fraternity across the country in its fold was a collaborative effort organized by Indian Pharmacy Graduates' Association- Student Forum (IPGA-Student Forum), Indian Pharmacy Graduates' Association (IPGA), Delhi Pharmaceutical Sciences and Research University and DPSR University Alumni Association.

The fest was also a hub of delicious food. Brands famous for fast food like LaPino'z, SadakChaap, South Indian Food Stall showcased their presence.

Panacea was also filled with fun games set up by the students of different colleges.

The fest was also joined by professional actors and Nukkad Natak specialists like Mr. Tarun Kohli, Mrs. Reeta Sharma, dancers like Ms. Arushi Solanki and Mrs. Shalini Solanki, Composers and Youtubers like Mr. Bali Kashyap, Celebrated poets like Mr. Aditya Mudgal, Women Entrepreneurs like Ms. Vaishvi Lakhina, Stylists like Ms. Samyukta, National Winner of EuroArts - Mr. Abhinav Sadana.

Lastly, we would also like to thank all the students and teachers who joined our event and contributed to its success. We will forever be in gratitude for their understanding, kindness and keenness to see all the wonders this event entailed and for allowing us to dream big and succeed.

PANACEA 2020-THE FESTIVAL OF DREAMS

STUDENTS ACTIVITIES

09

SPONSORS FOR THE EVENT:

STUDENTS ACTIVITIES

10

DAY ONE OF PANACEA 2020

Dr. Harvinder Popli, Principal-DPRSU also

enlightened the students and other faculty members of

DPSRU with her enchanting words and reminded us

the importance and need of a pharmacy centered

event such as Panacea 2020. The event concluded

with the release of our magazine –FARMAKON 2.0

The event commenced with the Inauguration

ceremony by felicitating Professor Dr. RK Goyal,

Vice-Chancellor, DPSRU, Shri Atul Kumar Nasa,

President, IPGA,Dr. Harvinder Popli, Principal and

Registrar, DPSRU and Dr. Arun Garg, General

Secretary, IPGA.

The President of IPGA-SF, Ms. Prabhleen Pahwa

commenced the ceremony with a welcome address

which was followed by an inspiring speech by Shri

Atul Kumar Nasa, President, IPGA and an

illuminating and encouraging speech by Prof. Dr. RK

Goyal-Vice Chancellor of DPSRU that resonated

with all present during the inauguration.

Events:

The day began with our first event, Nukkad Natak

which was made into a great success by 16

participating teams from all across Delhi NCR and

other states. Our esteemed judge for the event, Mr.

Tarun Kohli bestowed the students with enthusiasm

and reflected his passion for acting and drama onto

everyone present to witness the acts into play.

The winning teams, tied into first position were

Dhwani (ANDC) & Kranti (IINTM). The thought

provoking themes taken up by the teams and their

ability to involve the entire audience into a state of

internalization is what led the day into an

interesting start.

STUDENTS ACTIVITIES

11

Goonj, our group singing competition was next and

packed with beautiful voices resonating throughout

the campus. Our judge for the event was with our

winners - Nukul khanna & Shivam Ahuja.

“Present Your Mind At Silicon Gully” was another

interesting event with an impressive display of ideas

that are translated into something tangible - a product

or a service; this is what separates doers from

thinkers. Silicon Gully was all about innovation and

ideas that can change the way this industry works. We

congratulate our Winning Team: Avantika Bhatia and

Shriyani Roy and extend a special thanks to Mr.

Nitesh Chauhan and Dr. Harvinder Popli for judging

the event.

The young bright minds brought their distinction

from the rest of the crowd by finding solutions to

problems like no other. Eureka was an event made

precisely for such minds. A special thanks to our

judges, Ms.Bushra and Mr. Mayank Dhawan. We are

proud of our Winner- C S Sruthi from DPSRU.

“Eureka was a very new and unconventional event, where participants come up with policies that can fix the problems overlooked in pharmacy. Thanks for having me there as a judge. Great work. Keep it up” -

Ms. Bushra Shameem

The stage was shaking with the vibrant energy of the

dancing teams in Oorja and Utkarsh, our solo and

group dance competitions with esteemed judges Ms.

Arushi Solanki and Mrs. Shelina Solanki.

“It was a great honor to judge dance competition at the

event Panacea! The volunteers were hardworking

and took great care of us. We got amazing hospitality

and the event was well organized by the organizers. It

was a great experience being a part of the event and

would be glad to be a part of it in the coming future”-

Ms. Arushi Solanki and Mrs. Shalini Solanki.

STUDENTS ACTIVITIES

12

RANGEELA was one of the events to encourage young

artistic minds to show their creativity on the topic

"TRANQUILLITY". We are proud to announce our winner-

Muskan Verma- Maitreyi College, University Of Delhi. A

very special thanks to our judge Mr. Abhinav Sadana and

Prof. Sharad Wakode for selecting the best artist amongst

some very tough competition.

Sometimes you can find peace of mind by transferring

yourself to different situations. They are just reminders to

stay calm. While art therapy is one of the ways to stay calm

and bring out inner peace.

Mr.Ravie Solanky, the founder of The Social House and our

winners Darakshan Praveen from DIPSAR University. The

day ended with mind-blowing performances by bands

during Ride the Lightning competition which shook the

entire crowd with its music

The Hindi poetry competition, Alfaz brought us laughter,

tears and a new found admiration for people who can tangle

words into a beautiful web of poems that touched our souls.

A special thanks to our judge,

The Best Time to Take Walk for DiabeticsA surprising news that taking a

walk before eating brings down

the blood glucose levels. But

whether we take a walk before or

after food or both will bring down

the sugar levels.

The researchers have found that

intense physical activity (fast

walks) before meals help people

with insulin resistance to control

their blood glucose levels better

than the standard recommenda-

tion to get one daily 30 minutes

of moderate exercise.

Walk for 25 minutes, five days a

week is recommended. Walking is

also good for pre-diabetics in

controlling sugar levels.

Taking a walk after dinner is the

best for diabetics but before

dinner is still better.

STUDENTS ACTIVITIES

13

DAY TWO OF PANACEA 2020

Dramaturgy brought in some of the most amazing

teams with though revoking subjects that ranged from

poverty to politics. Our winning team Hansraj

College and Deshbandhu College (Dramanomics)

with our Best actor Yash (MAC) and Special mention

Samagra (MAIMS).

Knock-out saw an intense battle between

perspectives and ideas. With topics extending from

healthcare as a business propaganda to the immense

problems involving population control, our winners

battled head to head for the ultimate prize. We

congratulate our winners Tannu Dhingra (NIET) and

extend our special thanks to Dr. Aarti Thakkar for

lending her precious time to judge our participants.

Rap Battle: The Rap battle had no rules, themes,

limitations and boundaries. The rap battle saw an

overwhelming response with participants that stirred

up the crowd in a frantic anticipation to see who

Later in the evening, the most awaited event came

into action, Panacea 2020 Fashion show – Styled to

rock. We saw some amazing contestants with fashion

forward style and a walk that lit up the entire stage.

We congratulate the winners of Fashion show who

were adjudged as, Ms. Panacea: Varsha from SGT

University and Mr. Panacea: Lalit also from SGT

University.

We are very thankful to our judges Ms. Vaishvi

Lakhina and Ms. Samyukta for investing their time

and skills into our venture.

will win as participants went head to head against

each other in a battle of words, mind and speed.

Our winner- Ranvir Kumar (SGT University) was

one such contestant who impressed the judges and the

audience alike with his immaculate skills.We thank our judge Mr. Bali Kashyap

for his feedback on the event.

STUDENTS ACTIVITIES

14

Pharm Junkies (Quiz) the activity of brainstorming yourself to bring out the right answers. It was a game of accuracy and precision. Essentially comprising of elements of a standard quiz format but with a twist in terms of its applicability. The questions were no longer restricted to a theory-based foundation but rather forced the participants to scavenge their minds like a true Pharmacist by testing the practical applicability of their knowledge.

Our winning team: Anuj, Kushi and Sagar from DIPSAR University.

Sci-con consisted of visual display of research/review findings of the students in the form of a self – explanatory and unambiguous poster which ended up with a question and answer session with the individual involved. This event was judged by dignitaries including Dr. Shruti Chopra, Dr. Arun Garg, Dr. Amit Kumar and Dr. Swaminathan.

Our other events included PUBG battle and Snapshot, a photography event which concluded the events we had for PANACEA 2020.

Special mention and thanks to all our Sponsors for their whole hearted support and motivation in making this event

a grand success.

IPGA ADVISORY

Corona Virus – CoVid-19 Infection

Can mul�vitamins and immuno-boosters help in protec�ng individuals from the virus?

It is true that our physiology requires vitamins and minerals (such as vitamin A, C and zinc) to func�on normally. Higher doses have not been shown to make the system func�on be�er.

Every part of the body, including the immune system, func�ons be�er when protected from environmental assaults and bolstered by healthy-living strategies such as the following: • Not smoking; • Ea�ng a diet high in fruits and vegetables; • Exercising regularly; • Maintaining a healthy weight; • Avoiding drinking alcohol, or drinking only in modera�on; • Ge�ng adequate sleep; • Taking steps to avoid infec�on, such as washing hands frequently and cooking meats adequately;

• Trying to minimise stress. Stay Home Stay Safe

FAQs

Gazette Notification and Circulars

15

Gazette Notification and Circulars

16

17

Gazette Notification and Circulars

18

Gazette Notification and Circulars

19

Gazette Notification and Circulars

IPGA ADVISORY TO PHARMACISTS

Corona Virus 2019-nCoV InfectionExpert Consensus on Guidance and Preven�on Strategies for hospital pharmacists and

the pharmacy workforce :Source::Chinese Pharmaceu�cal Associa�on, Feb 6th 2020

The pharmacy department shall disinfect the poten�al contaminated objects periodically ,including object surfaces, the air, hands and prescrip�ons.

Object to be disinfected Type of disinfec�on drugs

Environmental object surface

Chlorine-containing disinfectant (1000mg/L), chlorine dioxide (500mg/L), 75% alcohol, etc.

Hands Alcohol-containing quick-drying hand disinfectant, chlorine-containing disinfectant,

hydrogen peroxide.

Skin 0.5% iodine-based disinfectant, hydrogen peroxide.

Mucosa 0.05% iodine-based disinfectant

Indoor air Per-ace�c acid, chlorine dioxide, hydrogen peroxide, etc.

Pollutant Chlorine-containing disinfectant (5000-20000mg/L),

disinfectant powder or bleach powder containing water absorp�on

Tex�les such as

clothes, bedding Chlorine-containing disinfectant(500mg/L), ethylene oxide

Prescrip�ons Ethylene oxide

20

Gazette Notification and Circulars

Gazette Notification and Circulars

21

IPGA ADVISORY

Corona Virus – CoVid-19 Infection

1. Alloca�on of addi�onal human resources to arrange shi�s to avoid overwork of pharmacists.

2. Pharmacists should be encouraged to consume a healthy diet.

3. To perform regular ac�ve health status monitoring, including checking body temperature and respiratory symptoms.

4. To adopt all measures to ensure pharmacists stay healthy while providing pharmacy services to pa�ents.(Use Mask, Hand hygiene, Sani�za�on, PPE etc.)

5. Pay a�en�on to the mental health & their emo�onal management.

6. Conduct mental counselling.7. Protect pharmacy staff from the infec�on

Circular

22

Circular

23

Circular

24

Circular

25

Circular

26

IPGA ADVISORY

Corona Virus – CoVid-19 Infection

1. Ensure safety and con�nuity of services2. Opening hours should be communicated and

displayed to the public at a visible place . 3. Contact with pa�ents/customers should be minimised

by dispensing medicines through a small window4. The boxes /cases used by wholesale distributors for

the delivery of medicines should be cleaned and disinfected before they are taken inside

5. Home delivery may be offered for pa�ents who may be have been advised home quaran�ne or isola�on, or who may belong to a higher risk group or have reduced mobility/or for pa�ents older than 65 years

6. Have adequate stocks of essen�al medicines and devices

7. Do not overcharge for any medicine8. Carry out full staff training Patient First

Circular

27

Circular

28

Tazverik by Epizyme Inc.

Tepezza by Horizon Therapeutics Ireland DAC

Tazverik (tazemetostat) is the first drug approved by FDA on 23 January, 2020 for the treatment of epithelioid sarcoma, a rare soft tissue cancer. Tazverik (tazemetostat) for the treatment of adults and pediatric patients aged 16 years and older with metastatic (when cancer cells spread to other parts of the body) or locally advanced (when cancer has grown outside the organ it started in, but has not yet spread to distant parts of the body) epithelioid sarcoma not eligible for complete resection (surgically removing all of a tissue, structure, or organ). Epithelioid sarcoma is a rare sub-type of soft tissue sarcoma that often occurs in young adults. The most common side effects for patients taking Tazverik were pain, fatigue, nausea, decreased appetite, vomiting and constipation.

Tepezza (teprotumumab-trbw)is the first drug approved for the treatment of thyroid eye disease. It is used for the treatment of adults with thyroid eye disease, a rare condition where the muscles and fatty tissues behind the eye become inflamed, causing the eyes to be pushed forward and bulge outwards (proptosis).The US FDA approved this drug on 21 January, 2020. The most common adverse reactions observed in patients treated with Tepezza are muscle spasm, nausea, alopecia (hair loss), diarrhea, fatigue, hyperglycemia (high blood sugar), hearing loss, dry skin, dysgeusia (altered sense of taste) and headache.

Trikafta by Vertex Pharmaceuticals

Adakveo by Novartis

The U.S. Food and Drug Administration granted approval to Givlaari (givosiran) on 20 November 2019 for the treatment of adult patients with acute hepatic porphyria, a genetic disorder resulting in the buildup of toxic porphyrin molecules which are formed during the production of heme (which helps bind oxygen in the blood). “This buildup can cause acute attacks, known as porphyria attacks, which can lead to severe pain and paralysis, respiratory failure, seizures and mental status changes. These attacks occur suddenly and can produce permanent neurological damage and death. Common side effects for patients taking Givlaari were nausea and injection site reactions. Givlaari also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.

Fetroja by Shionogi & Co., Ltd.

The U.S. Food and Drug Administration approved Trikafta (elexacaftor/ivacaftor/tezacaftor) on 21 October 2019 .It is the first triple combination therapy available to treat patients with the most common cystic fibrosis mutation. Trikafta is approved for patients 12 years and older with cystic fibrosis who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator

(CFTR) gene, which is estimated to represent 90% of the cystic fibrosis population.

It is an antibacterial drug for treatment of patients 18 years of age or older with complicated urinary tract infections (cUTI), including kidney infections caused by susceptible Gram-negative microorganisms, who have limited or no alternative treatment options. The U.S. Food and Drug Administration approved Fetroja (cefiderocol)on 14 November 2019. The most common adverse reactions observed in patients treated with Fetroja included diarrhea, constipation, nausea, vomiting, elevations in liver tests, rash, infusion site reactions, candidiasis (yeast infection), cough, headache and hypokalemia (low potassium).

It is the first targeted therapy approved for painful complication of sickle cell disease. It was approved on 15 November 2019. It is used to reduce the frequency of vaso-occlusive crisis – a common and

Givlaari by Alnylam Pharmaceuticals.

SCIENTIFIC AND NEW DRUGS UPDATES

Scientific & New Drugs

29

30

Scientific & New Drugs

Padcev is a potent anticancer drug which got FDA approval on 18 december 2019 .This drug is used in the treatment of refractory bladder cancer . Padcev (enfortumabvedotin-ejfv), a Nectin-4-directed antibody and microtubule inhibitor conjugate, meaning the drug specifically targets cancer cells – in this case, the cell adhesion molecule Nectin-4, which is highly expressed in urothelial cancers. Padcev is indicated for the treatment of adult patients with locally advanced (when cancer has grown too large to be surgically removed) or metastatic (when cancer cells spread to other parts of the body) urothelial cancer.

Xycopri bySK Life Science Inc.

This drug was approved on 25 November 2019 by US FDA. Oxbryta in which the active ingredient is voxelotor is used for the treatment of sickle cell disease (SCD) in adults and pediatric patients 12 years of age and older. Oxbryta is an inhibitor of deoxygenated sickle hemoglobin polymerization, which is the central abnormality in sickle cell disease. Common side effects for patients taking Oxbryta were headache, diarrhea, abdominal pain, nausea,

fatigue, rash and pyrexia (fever).Oxbryta also received Orphan Drug designation, which provides incentives to assist and encourage the development of drugs for rare diseases.

Oxybryta by Global Blood Therapeutics.

Padcev by Astellas Pharma US Inc.

The U.S. Food and Drug Administration approved XCOPRI (cenobamate tablets) on 21 November 2019 to treat partial-onset seizures in adults.“XCOPRI is a new option to treat adults with partial-onset seizures, which is an often difficult-to-control condition that can have a significant impact on patient quality of life. XCOPRI should not be used in patients with hypersensitivity to cenobamate or any of the inactive ingredients in XCOPRI or Familial Short QT syndrome. QT shortening can be associated with ventricular fibrillation, a serious heart rhythm problem. The most common side effects that patients in the clinical trials reported were somnolence (sleepiness), dizziness, fatigue, diplopia (double vision), and headaches.

painful complication of sickle cell disease that occurs when blood circulation is obstructed by sickled red blood cells – for patients age 16 years and older. Adakveo specifically inhibiting selectin, a substance that contributes to cells sticking together and leads to vaso-occlusive crisis. Common side effects for patients taking Adakveo were back pain, nausea, pyrexia (fever) and arthralgia (joint pain).

Reyvow byEli Lilly and Company

The U.S. FDA approved Reyvow (lasmiditan) tablets on 11 October 2019. It is used for the acute (active but short-term) treatment of migraine with or without aura (a sensory phenomenon or visual disturbance) in adults. There is a risk of driving impairment while taking Reyvow. Patients are advised not to drive or operate machinery for at least eight hours after taking Reyvow, even if they feel well enough to do so. The drug causes central nervous system (CNS) depression, including dizziness and sedation. The most common side effects that patients in the clinical trials reported were dizziness, fatigue, a burning or prickling sensation in the skin (paresthesia), and sedation.

Torrent Pharmaceuticals puts faith in local

market, to focus on new drug launches:

The growth trajectory for the Indian pharmaceutical

industry is likely to remain at 10-13 per cent in 2020-

21 despite challenges, according to rating agency

ICRA. According to ICRA, The expected growth in

the next financial year is on the back of healthy

demand from the domestic market given increasing

spend on healthcare along with improving access.

This along with abatement in pricing pressure for the

US market, new launches and market share gains for

existing products and consolidation benefits will

drive growth in 2020-21, it added.

Glenmark sells gynac business for Rs 115 crore:

Glenmark Pharma has sold its gynaecology business

to private equity firm True North backed Integrace

Pharma in an attempt to cut down debt of the

company. The sale of the gynac business comes two

years after it sold its orthopedic business to the same

company. Integrace will pay Rs 115 crore for four

products of the portfolio that includes products like

Dubagest, Mumfer and Fenza. These three products

currently have sales of Rs 60 crore and are growing by

15%.

Eli Lilly, Sitryx announce autoimmune alliance:The Ahmedabad-based company, part of the Rs

14,000-crore Torrent Group, is the only domestic

pharma co that has invested nearly $1 bn in local

acquisition over the last three years. It expects its

future growth avenues from India, Brazil and

Germany. The company also focuses on the launch of

products in the segment of cardiology and diabetes,

which is the fastest growing segment in India. Torrent

Pharmaceuticals is optimistic that the future of Indian

drug makers is in the domestic market, as it looks at

new launches in the lucrative chronic therapy areas.

Eli Lilly has revealed a new global licensing and

research collaboration with Sitryx, in order to study

up to four novel preclinical targets identified by. The

collaboration is set to grant Lilly an exclusive,

worldwide license to develop and commercialise up

to four novel immunometabolism targeted

therapeutics, including Sitryx's two lead projects,

leading to a a five-year research collaboration to

support the development of the therapeutics. The

companies have confirmed that under the terms of the

agreement, Sitryx will receive an upfront payment of

$50 million, and Lilly will make a $10 million equity

investment in Sitryx. Also, the latter will be eligible to

receive potential development milestones up to $820

million, as well as commercialisation milestones and

royalty payments on potential sales in the mid- to

high-single digit range.

Unichem, Macleods recall drugs for blood

pressure, diabetes from US market:

Unichem is recalling 1.91 crore units of Clonidine

Hydrochloride tablets from the US market because of

failed impurities/degradation specifications. This

recall is initiated as a precautionary measure due to

potential migration of Benzophenone at very low

level into product from container label, the United

States Food and Drug Administration(USFDA) said

and Macleods is recalling 4,694 bottles of

Pioglitazone and Metformin Hydrochloride tablets

used for treating high BP because of subpotent drug:

out of specification assay result, below specification,

for two lots of Pioglitazone And Metformin

Hydrochloride tablets, the USFDA said.

Indian pharma industry likely to grow at 10 to 13

per cent in FY'21 ICRA:

PHARMACEUTICAL INDUSTRY UPDATES

Industry Updates

31

32

SkanRay, the leading ventilator manufacturer has

created a consortium with BEL, BHEL & Mahindra to

ramp up production from standard 2000 pieces per

month to currently 5000 pieces per month and 30,000

pieces per month by May.

Dyson, a bagless vacuum cleaner and hand sanitizer

company is working alongside The Technology

Partnership to develop its new system, called The

CoVent. It has already begun work at the RAF

Hullavington technology campus after receiving an

initial order of 10,000 units from the UK government

and will donate another 5,000 to the international

effort. The device is safe, effective, efficient in

conserving oxygen, easy to use, bed-mounted,

portable and not needing a fixed air supply. CoVent

meets the clinician-led specifications, to address the

explicit clinical needs of COVID-19 patients.

Various Liquor manufacturers and sugar mills have

stepped forward to meet the increasing demands of

sanitizers. Jagatjit Industries that makes liquor

brands such as Aristocrat whisky has initiated the

manufacture and supply of sanitizers. Chennai-based

packaged consumer goods company CavinKare

launched hand sanitizers under its popular personal

care brands – CHIK, Nyle, and Raaga. Jubilant Life

Sciences announced that its research and

development team has developed formulation for

hand sanitizer using ethanol produced at its plants.

Dr Reddy's to acquire part of Wockhardt's India

business for Rs 1,850 crore:

Dr Reddy's Laboratories on Wednesday announced

an agreement with Wockhardt Ltd. to acquire select

divisions of its branded generics business in India,

Nepal, Sri Lanka, Bhutan and Maldives for a

consideration of Rs 1,850 crore. The agreement

comprises a portfolio of 62 brands in multiple therapy

areas such as respiratory, neurology, VMS,

dermatology, gastroenterology, pain and vaccines.

Wockhardt will transfer Dr Reddy's related sales and

marketing teams; and the manufacturing plant located

in Baddi, Himachal Pradesh with all plant employees.

The business undertaking is being transferred on a

slump sale basis, according to the company.

1. Medical Devices like ventilators

Various medical equipment manufacturers have

joined hands with automotive industries to fasten the

production of ventilators for the critically ill patients.

Indian medical device manufacturers have drawn up

plans to deliver 50,000 ventilators by May to meet the

growing demand for life-saving devices during the

COVID-19 outbreak.

AgVa has tied up with Maruti to scale up production

from 400 pieces per month to 4000 pieces per month

in April to 10,000 pieces per month by May.

2. Sanitizers

Seeing the surge in the demands of sanitizers, various

companies have also reduced prices of their sanitizer

brands to make it more accessible and affordable.

3. Testing Kits manufactured in India

Under Mylab's, research and development chief,

Minal Dakhave Bhosale, the corona virus testing kit

called Patho Detect was developed in just six weeks.

Mylabs Discovery Solutions, which received

statutory approvals from authorities, can manufacture

over 15,000 testing kits per day from its facility at

Lonavala in Pune district and the same will be ramped

up to 25,000 kits per day.

4. Drugs and vaccines

Various big pharma companies have put forth their

plans and means of fighting this pandemic through the

development of vaccines and drugs. Some of them

have been indicated below-

a. Gilead is working on the Remdesivir for

treatment of COVID-19 patients. It has initiated two

Industry Updates

33

Industry Updates

c. AbbVie collaborating with health authorities and

institutions globally to determine antiviral activity as

well as efficacy and safety of KALETRA®/Aluvia

(lopinavir/ritonavir), AbbVie's antiretroviral therapy

for the treatment of HIV, against COVID-19.

h. Japanese pharma giant Takeda is at work on a

treatment derived from the blood of people who have

already been infected by the corona virus. The

company is drawing blood from corona virus

survivors, harvesting the plasma, and then isolating

the protective antibodies that kept those patients

alive.

e. Arcturus Therapeutics and Duke-NUS Medical

School (Duke-NUS) partner to develop a Corona

virus (COVID-19) vaccine for Singapore. The

development of a COVID-19 vaccine will be based on

the company's STARR technology and will take

advantage of a unique platform developed at Duke-

NUS allowing rapid screening of vaccines for

effectiveness and safety.

d. Moderna is developing a vaccine- mRNA-1273

that was identified just 42 days after the novel corona

virus was sequenced. The company is working with

the National Institutes of Health on a healthy-

volunteer study that began earlier this month.

I. Gujarat-based company Zydus is a leading

producer of hydroxychloroquine (HCQ) and it has

already increased its capacity to make both the API

and the formulation manifold.

g. Eli Lilly has partnered with a Canadian firm called

AbCellera to develop antibody treatments for corona

virus infection. Using a blood sample from a corona

virus survivor, AbCellera identified more than 500

antibodies that might protect against the virus.

f. CureVac uses man-made mRNA to spur the

production of proteins. It got a grant from the

nonprofit Coalition for Epidemic Preparedness

Innovations to apply its technology to corona virus.

CureVac expects to start the clinical trial Phase I by

early summer 2020.

Phase 3 trials to evaluate the safety and efficacy of

remdesivir in adults diagnosed with COVID-19

following the U.S. Food and Drug Administration's

(FDA) rapid review and acceptance of Gilead's

investigational new drug (IND) filing. These

randomized, open-label, multicenter studies began

enrolling patients in March 2020 and will enroll a

total of approximately 1,000 patients in the initial

phase of the studies, in countries with high prevalence

of COVID-19.

b. Pfizer collaborates with BioNtechfor the

development of the new mRNA vaccine initially to

supply in the United States and Europe and scale-up

manufacturing capacity to support global supply of

millions of vaccine doses by the end of 2020 subject to

technical success of the development program and

approval by regulatory authorities, and then rapidly

scale up capacity to produce hundreds of millions of

doses in 2021.

The Best Time to Take Walk for Diabetics

Walk for 25 minutes, five days a

week is recommended. Walking is

also good for pre-diabetics in

controlling sugar levels.

Taking a walk after dinner is the

best for diabetics but before

dinner is still better.

The researchers have found that

intense physical activity (fast

walks) before meals help people

with insulin resistance to control

their blood glucose levels better

than the standard recommenda-

tion to get one daily 30 minutes

of moderate exercise.

A surprising news that taking a

walk before eating brings down

the blood glucose levels. But

whether we take a walk before or

after food or both will bring down

the sugar levels.

Throwing light on the topic of Research Directions, Dr. Kanchan Kohli explained the role of ICMR and other Government funding agencies, Prof. (Dr.) Arun Garg, Professor Pharmacology and General Secretary of IPGA, discussed about under trial drug Remdesivir. Dr. Satyendra Kr. Rajput, Director Amity Institute of Indian Medicine encouraged all the participants to practice yoga, meditation and consume immunity boosting drinks and food to fight COVID-19.

Some of the illustrious dignitaries who were present all along the Conclave included Sh. Shripati Singh, Sh. Bharat Bhushan Dr Ajay Sachan, Dr. Jey Balan Govindaswamy, Dr. Rahul Garg, Dr Abhishek Singh and Dr. Neerupma Dhiman.

Ms. Silky Sethy concluded the session by proposing the vote of thanks..

The Conclave proved to be a very informative Webinar organized by IPGA in collaboration with Amity University and was well appreciated by the participants.

Indian Pharmacy Graduates'Association along with Amity University organized its First National Conclave Online on May 10, 2020. The conclave was enlightened by more than 25 experts and was participated by more than 1000 participants. The theme of the conclave was: : The next Generation Pharmacist: “Digitalization, The Regulatory Mechanisms, The Research Directions and Future Jobs”. It was chosen in the prevailing uncertainty amongst the students of pharmacy fraternity due to the Pandemic COVID-19. Dr Vijay Bhalla, convened the online webinar which was attended by more than 2300 participants.

On the topic Digitalization, Mr. B.R. Sikri, a renowned businessman and a successful Pharmaceutical Entrepreneur addressed the young pharmacists on the current scenario of Pharmaceutical industry vis a vis untapped opportunities in the making of a self reliant India.

While speaking on Regulatory Mechanisms Mr Pawan Kumar Jaggi, Ex-Head of Office, Drugs Control Department, Delhi enlightened the students on the role of Drug Control Officers in maintaining the supply chain during pandemic. Mr. Atul Kumar Nasa, President IPGA explained how the Govt. and Drug Control Departments both at center and state level are playing a dynamic role in fighting this Pandemic of Covid-19.

Dr. Vijay Bhalla, Dean, SGT University played an important role in organizing the conclave. Dr Bhalla , Dr M N Rao and Dr Arti Thakkar elaborated on the topic Future Jobs for young budding pharmacists.

Seminar Report

34

IPGA CONCLAVE 2020: NEXT GENERATION PHARMACIST Sunday, May 10th 2020

The main aim for the establishment of the IPGA-WF

is to provide a national platform enabling women

Pharmacists to expand pharmaceutical opportunities

and strengthen their role in the profession. Further it

was discussed and approved by the CEC members

that various awareness programmes related to women

health such as post-partum depression, pregnancy

care, menopausal issues diet & nutrition and other

related issues must be carried out throughout year.

The following hierarchy was approved for framing

the IPGA Women Forum.

In October 2019, Dr. Kanchan Kohli, Professor and

Head, Pharmaceutics, School of Pharmacy, Jamia

Hamdard, New Delhi and Dr. Arti R. Thakkar,

Associate Professor, AIP, Amity University, Noida

were unanimously selected as a Convener and co-

convener of the IPGA-Women Forum (IPGA-WF).

WOMEN'S FORUM UPDATES

Women's Forum

35

Further, In March, 2020 nominations were invited from across India for different positions of the Women Forum

Executive committee. After screening of the few applications following candidates have been selected on various

positions of the women forum central executive committee.

(As a women forum representative in working division of IPGA)1. Academic2. Industrial3. Pharmacy practice4. Public Relation5. Regulatory Affairs

Covener

Co-Covener

CouncilMembers (5)

ZonalCoordinators

Chair toSections

North South East West Central

StateCoordinator Co-cordinator

Convener

Co-Convener

PositionS.No. Names Designation

1

2

Dr. Kanchan Kohli

Dr.Arti R Thakkar

Professor and Head, Pharmaceutics, School of Pharmacy,

Jamia Hamdard, New Delhi

Associate Professor, AIP, Amity University, Noida

Council Members

1

2

3

Dr. Neerupma Dhiman

Dr. Kriti Soni

Ms. Archu Singh

Associate Professor, AIP, Amity University, Noida

Head, F&D, Dabur Research Foundation, Shahibabad, Gaziabad, UP, India

PhD Scholar, School of Pharmacy, JamiaHamdard, New Delhi.

Women's Forum

36

Central Zone

North Zone

South Zone

1

2

3

Dr. Kamala Pathak

Dr. Ramanpreet Walia

Dr. Sanju Dhawan

Professor, Faculty of Pharmacy, Uttar Pradesh University of

Medical Sciences, Saifai, UP

Associate Professor, AIP, Amity University, Noida

Head- Product Development IKKT, Pfizer Healthcare,

SIPCOT Industrial Park, Irungattukottai, Sriperumbudur (Tk),

Tamil Nadu, India

Zonal Coordinators

Panjab

Uttar Pradesh

Gujarat

Maharashtra

Uttar Pradesh

1

2

3

4

5

Dr. Prerna Swarup

Dr. Neeraj

Dr. Nikunjana Patel

Dr. Dipti Ruikar

Dr. Sarita Yadav

Principal, Swami Vivekanand College of Pharmacy,

Banur, Patiala, Panjab

Director, RPS College of Pharmacy, Barabanki, UP

Associate Professor, Shree S. K. Patel College of

Pharmaceutical Education and Research, Ganpat University,

Mehshana, Gujarat

HOD and Associate Professor, School of Pharmacy,

GH Raisoni University, Amravati, Maharashtra

Assistant Professor, Department of Pharmacy,

Moti Lal Nehru Medical College, Allahabad-UP

State Coordinators

If anyone is interested to be part of the IPGA Women Forum they can send their names, brief profile alongwith email

id for consideration and approval on the following email ID: ipga.womenforum@gmail.com

Few positions such as East Zone and West Zone coordinators, different state coordinators and council members,

require to be filled.

BEST FOODS FOR DIABETICS1) CINNAMON : Research has suggested that cinnamon, in type-2 diabetes, helps to reduce blood glucose levels and increase insulin sensitivity. It improves insulin receptor function by activating enzymes that cause insulin to bind to cells (insulin receptor-kinase) and inhibits enzyme that blocks this process. 6 gms per day reduces LDL, Cholesterol and triglycerides. If 6 gms is taken for 40 days, can drop the blood glucose level by 25%.Best form is to brew cinnamon like tea and drink.

2) JAMMUN Total jammun fruit is very effective in diabetes. Seeds are rich in alkaloids which have hypoglycemic effect. They also increase insulin activity and sensitivity. 1 gm of powder taken three times a day can bring down the level of glucose by 30%.

3) ONION Contains high quantity of flavonoids (quercetin, cysteine, allyl propyl disulphide) which have the property to lower the sugar levels in diabetes.50 gms of onion extract as juice controls the post prandial glucose levels.

4) FENUGREEK SEEDS It contains fibers and chemicals which slows digestion of carbohydrates and sugar. It also increases the insulin release. 4, hydroxyleucine- a novel amino acid present in seeds increases glucose simulated insulin release by isolated islet cells.In the morning drink 10 gms of seeds soaked in hot water over night.

5) ALO-VERA Alo-vera is packed with glucomannan which reduces glucose levels. The other components like anthraquinones, organic phenols and

lectins also regulate the sugar levels. Alo-vera cleans the body and eliminates excess glucose in the blood stream. It stimulates the secretion of insulin from the pancreatic beta cells. Alo-vera juice 50 ml taken twice a day regularly for two months brings a substantial change in sugar levels.

6 ) B R O C C O L I B r o c c o l i c o n t a i n s phytochemical Sulforaphane which can reverse the damage diabetes inflict on the blood vessels. It is recommended for diabetics because it contains antioxidant, minerals, vitamins and low calories. Broccoli also contains chromium which is required for GTF ( glucose tolerance factor) thus helps to metabolize blood sugar. Broccoli should not be cooked but eaten in salads or stir fried.

Tribute

37

He was very keen to do Masters in Pharmacy. Professor N.K. Basu, Head of the Department of Pharmaceutics, Banaras Hindu University (BHU) accepted him for admission for the session starting in July 1951. The M. Pharm course at BHU was of one year duration and only by research. Professor Basu asked him to work on the chemical examination of Achyranthes aspera Linn. This was his first exposure to work on a medicinal plant and handling of a quaternary ammonium compound, Betaine. He completed his M. Pharm in May 1952 and got a good job in the industry. However, this yearning for further research made him to accept appointment at the BHU as a part-time lecturer. The appointment was only for a couple of months. He resigned a well-paid job in industry to join BHU in November 1952 on a salary of Rs. 180 per month. Luckily, he was appointed as a temporary lecturer in a leave vacancy. He joined the BHU faculty in February 1953 and continued in the position up to January 1956. During this period of lectureship, he also worked for his doctoral thesis, again under Prof. Basu.

Fraternity of Pharmacy was shocked to know about the sudden sad demise of Professor Harkishan Singh on 20 March, 2020. With his death, the Golden Sun of Pharmacy Profession has set forever. In India, no other pharmaceutical professional has done as much work as an academician, research scientist, historian and an active promoter of cause of pharmacy as Professor Singh.

He worked on the investigation of chemical constituents of Orthosiphon pallidus Royle, submitted his thesis in November, 1955 and got his Doctorate in 1956. He had published two papers in the Scientific Edition of Journal of American

Harkishan Singh was born on 25th November, 1928 in a village in Lyallpur district (now in Pakistan). He was the eldest of the five children of Shri Subeg Singh and Shrimati Kirpal Kaur belonging to the village Khara in Amritsar district. Shri Subeg Singh was in postal service and worked at different places in India, finally retired in 1963 from Hyderabad. He had done his matriculation and F.Sc. Intermediate from Panjab

University. In April 1948, Harkishan Singh joined B.Pharm at Medical College, Amritsar and obtained his B a c h e l o r ' s d e g r e e i n Pharmacy in 1950, standing first in the order of merit. Shortly after completing his d e g r e e , h e h a d t h e opportunity to work for a couple of months at the Drug Research Laboratories, Jammu, of which Col. Sir Ram Nath Chopra was the Director. It was a great privilege for him to be under

ththe tutelage of this great savant of the 20 Century.

A TRIBUTE TO GURU DEV : PROFESSOR HARKISHAN SINGHDr. T.R. Bhardwaj

(Vice-chancellor, Baddi University of Emerging Sciences and Technology, Baddi, Himachal Pradesh- Former Chairman, UIPS, P.U., Chandigarh).

Dr. T.R. Bhardwaj

Tribute

38

Dr. Singh served as Lecturer in Pharmaceutical Chemistry, Banaras Hindu University, 1953-1956; Assistant Professor of Pharmaceutical Chemistry, University of Sauger, 1956-1964; Reader in Pharmaceutical Chemistry, Panjab University, 1964-1972; Professor, Pharmaceutical Sciences (Pharmaceutical Chemistry), Panjab University, 1972-1988.

Dr. Singh got married in June, 1958. His wife Mrs Gian was a personality radiating warmth in relationship and concerned about the individual problems of all who-so-ever came in the contact of her. By virtue of her interest in social milieu, she had ever remained a key figure on the University campus. Prof. Singh's main source of strength and best companion was his wife, with whom he was happily married for 40 years. They had two children- Tript and Dr. Manjeet, both are settled in United States.

Dr. Singh spent around five academic years abroad working at Universities of Maryland, USA (1958-1961), Mississippi, USA (1967-1968) and London, UK (1971-1972). He was Head of the Department of Pharmaceutical Sciences, Panjab University (1976-1981) and Founder Dean of the Faculty of Pharmaceutical Sciences, Panjab University (1981-1985). He was also Dean of Alumni Relations, Panjab University (1979-1984). He was a National Fellow of the University Grants Commission (UGC) at the Panjab University (1985-1987), being the only person in Pharmaceutical Sciences to get this honour from the UGC.

POSITIONS HELD

Professor Harkishan Singh was conferred Padma Shri by President of India Hon'ble Pranab Mukherjee in 2017. He was conferred with almost all awards and honours for his research and professional contributions. He was the recipient of Illustrious Faculty Award, Diamond Jubilee Celebrations, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Vishwavidhyalaya, Sauger, M.P. 2016; Doctor of Science (Honoris Causa) conferred by the Panjab University, Chandigarh, 2016; Lifetime Achievement Award, Panjab Academy of Sciences, 2015; Doctor of Science (Honoris Causa) conferred by the University of the Sciences in Philadelphia, Philadelphia, Pennsylvania, USA, 2014; Shri Raman Bhai B. Patel Foundation Lifetime Achievement Award, Indian Pharmaceutical Association, Mumbai, 2010; Lifetime Achievement Award, Indian Pharmaceutical Congress, Banaras Hindu University, 2007; Shri Bhojraj Panjamool Lifetime Achievement Award, Association of Pharmaceutical Teachers of India, 2007; Lifetime Achievement Award, Chandigarh Science Congress, 2007; Lifetime Achievement Award, Uttar Pradesh Technical University, 2006; elected Honorary Fellow, Panjab Academy of Sciences, 2001; Eminent Pharmacist Award, Indian Pharmaceutical Association, Mumbai, 1999; Schroff Memorial National Award, Indian Hospital Pharmacists' Association, New Delhi, 1998; elected member, Academic Internationale d' Histoire de la Pharmacie, 1995; Golden Jubi lee Commemoration Award, The Pharmaceutical and allied Manufacturers and Distributors Association Limited (PAMDAL), Bombay, 1991; Ranbaxy Research Award in Pharmaceutical Sciences of the Ranbaxy Research Foundation, New Delhi, 1987; National Fellow, University Grants Commission, 1985-1987; Professor G.P. Srivastava Memorial Award, Association of Pharmaceutical Teachers of India (APTI), 1983; Acharya P.C. Ray Memorial Gold Medal, Indian Pharmaceutical Association, Bengal Branch, Calcutta, 1982; Distinguished Alumnus Award, Institute of Technology, Banaras Hindu University; Shri Amrut Mody Research Foundation Award, Bombay, 1975. Professor

Pharmaceutical Association. These publications gave a good beginning to Dr. Singh to build his further research career. Dr.Harkishan Singh moved to the University of Sauger in 1956 to join as Assistant Professor of Pharmaceutical Chemistry. Later, in 1964, he joined Panjab University as a Reader rising to the position of Professor in 1972.

Dr.Harkishan Singh was Professor Emeritus Panjab University since 2003 and Emeritus Fellow (UGC) Panjab University, 1989-1992.

AWARDS AND HONORS

Tribute

39

OTHER PROFESSIONAL AND ACADEMIC RECOGNITIONS

RESEARCH

Professor Singh had been associated with the working of several professional and statutory organizations and held important position in these bodies. He was member of the Pharmacy Council of India (PCI) (1970 -1981, 1987 -1992); PCI Executive member (1977-1981) and a member of the Drugs Technical Advisory Board, Ministry of Health, Government of India (1978-1983). He was President of Association of Pharmaceutical Teachers of India (1974 ,1975). He was a member of the standing committee on Pharmaceutical Education, Federation of Asian Pharmaceutical Association (1976-1978) and Committee on Education in Medicinal Chemistry, International Union of Pure and Applied Chemistry.

Harkishan Singh was the President, India Pharmaceutical Congress, thirty third session, Jaipur, 1981. He had delivered Panjab University Pharmaceutical Sciences Oration, Chandigarh, 1998; Bawa Kartar Singh Memorial Lecture, Department of Chemistry, Panjab University, Chandigarh, 1992-1993; Pharmacy Department Silver Jubilee Lecture, Andhra University, Waltair, 1987; Professor M.L. Khorana Memorial Lecture, Indian Pharmaceutical Association, Bombay, 1984.

Research and education had been a lifetime passion with Professor Singh. He has done extensive research in Medicinal and Pharmaceutical Chemistry. Forty-eight doctorate and master theses were completed under his supervision. His primary areas of research had been natural products and heterosteroids. The medicinal plant studied by Professor Singh and his

group were Asteracantha longifolia nees (V.V Parashar), Strychnos potatorum Linn. (V.K. Kapoor), Erythrina Subrosa Roxb and other Erythrina species (A.S Chawla). He was also interested on geometrical enantiomerism which was demonstrated through resolution of (tropinone oxime (B.K. Razdan).

Later, work on the design and synthesis of bis-onium steroids as potential neuromuscular blocking agents was initiated at Panjab University which led to the discovery of Chandonium iodide (HS -310) (D.P. Jindal) after the name of Chandigarh city and other related analogues (T.R. Bhardwaj). After detailed follow-up, toxicity and clinical studies, the drug was cleared by the Ministry of Health, Government of India, for manufacture and clinical use. This synthetic neuromuscular blocker is the crowning feature of research of nearly three decades.

Professor Singh's publications include 21 books (including 9 history monographs); 6 books chapters and 16 other review papers. He had 125 original research papers in Medicinal Chemistry, more than 65 research papers on pharmaceutical history, over hundred articles on pharmaceutical education, professional issues and other topics. Fourteen patents had been obtained for his work on heterosteroids.

Professor Singh had delivered several invited lectures at Institutions and conferences within India, United States of America, United Kingdom, Canada and China. He delivered invited lectures at the Harvard Medical School and at the International Symposium on Molecular Structure (1986) sponsored by the International Union of Crystallography at Beijing, China.

His major research interest however, remained on heterosteroids. Professor Singh's research on heterosteroids was started in 1958 as Post-doctoral Research Fellow in Pharmaceutical chemistry with Dr. Norman J Doorenbos, University of Maryland, USA.

After his retirement in 1988, Prof. Singh revived his interest in the study of history of Pharmacy in India. He had collected rare archival material through his visits to different libraries in India and abroad. Unfortunately, Mrs. Singh passed away in 1998. With great courage and willpower to overcome the grief he continued his research on history of pharmacy in India and also participated in other professional activities. He has organized his collection appropriately into over twelve hundred volumes.

It is rare that new drugs get discovered in the University laboratories. Candocuronium is the International Non-proprietary Name (INN) given to the drugs by the World Health Organization, Geneva.

Tribute

40

PERSONAL ASSOCIATIONS AND VIEWS

Professor Harkishan Singh was known to me since 1968 when I joined University Institute of Pharmaceutical Sciences (Formerly Department of Pharmaceutical Sciences), Panjab University, Chandigarh, for my B. Pharm degree. However, my close association with him started in July, 1972 during my M. Pharm 2nd year, which I completed in 1973. Working under his guidance has not only motivated but also enhanced my passion for research. The interest in the exploration of science further deepened when I joined doctoral program, as Senior Research Fellow (CSIR) again under his supervision. During my Ph.D., I joined parent Institute as lecturer in Pharmaceutical Chemistry in September, 1976. In 1978, I was awarded Ph.D. degree in the Faculty of Medicine. Five Indian patents and more than 10 research papers had been published out of my M. Pharm and Ph.D. work under his supervision. Since then my association with my mentor became stronger and stronger, over a span of around 48 years.

Professor Singh was always keen to derive newer techniques in imparting training at the post graduate level. He introduced workshop system of imparting instructions in which students were made to take active part in the process of learning.

Professor Singh was a person with strong convictions and firm views, on which he never compromised. He was a voracious reader and a prolific writer. For each book or journal, he read, he kept a record of the passages that stirred his mind and soul. As a lover of words and phrases, he tried to use them appropriately in his writings. He always kept himself intellectually informed and mentally sound.

Professor Singh had great reverence to his teachers. He derived inspiration from those who made significant contribution to science and society. This is reflected in the dedication of books authored by him to the memory of his teachers.

Professor Singh had been instrumental in bringing up the University Institute of Pharmaceutical Sciences (UIPS), Panjab University to its present status of foremost Centre of Education and Research in Pharmaceutical Sciences in the country.

Through his research, many unknown facts have been rediscovered. As per his will, Prof. Singh transferred his library to the National Heritage Centre, National Institute of Pharmaceutical Education and Research, SAS Nagar (Mohali). Those who are interested to further explore history of pharmacy can make use of this huge rare collection of Archival material and documents which is available at the National Heritage Centre.

Pharmacy profession will remain indebted to Professor Harkishan Singh forever for his incessant hard work, significant contribution and foresigh-tedness in the upliftment of the profession.

“We pray to the Almighty to impart peace to the departed soul and give enough courage and strength to his family members to bear the irreparable loss.”

Future generation of pharmacy professionals would continue to derive inspiration from the deeds and services rendered to the pharmacy profession by this great educationist and researcher.

On my first day with Professor Singh, he enumerated three qualities which are prerequisite for the good researcher- honesty, hard work and ingenuity, in that order. His advice to his students in general was, “to own your country and work for it”.

The better status of Pharmacy profession in India as a whole is the result of sustained and collective efforts made during last 60 years by many Pharmaceutical luminaries and intellectuals including the substantial efforts of Professor Singh. The primary professionals struggled for almost four decades for the establishment of Central Institute of Pharmacy. Professor Singh kept on lecturing and writing on the subjects which are well documented. He was instrumental in the establishment and academic structuring of National Institute of Pharmaceutical Education and Research at S.A.S. Nagar (Mohali) in 1991.

IPGA NEW MEMBERS

41

Photographs of some of the new members couldn't be printed due to Due to Non Availability of High Resolution Photograph.

All such members are requested to forward soft copy of their photographs at pawankr52@gmail.com alongwith their Name and LM Number.

6701

Mr. Mahebbor Rahaman

6702

Mr. Sukhendu Mondal

6703

Mr. Partha Saha

6704

Mr. Gourav Sanajdar

6705

Mr. Goutam Roy

6706

Mr. Prokash Halder

6707

Mr. Santanu Prosad Dutta

6708

Mr. Sudip Kumar Ganguly

6709

Mr. Rajiul Alam

6710

Mr. Ratan Majumder

6711

Mr. Amit Kumar Ghosh

6712

Mr. Koushik Maity

6713

Ms. Sayanika Ghosh

6714

Dr. Arti Singh Singh

6715

Mr. Pratham Bhatia

6716

Ms. Nancy

6717

Mr. Sehajpreet Singh

6718

Mr. Piyush

6719

Ms. Himani Yadav

6720

Ms. Bhawna Bansal

6721

Ms. Bhavika

6722

Mr. Rahul Dagar

6723

Ms. Sruthy Varghese

6724

Mrs. Anita Kurup

6725

Ms. Aleesha Mathew

6726

Mr. Vaibhav Goel

6727

Ms. Shivam Sharma

6728

Ms. Tanya Agarwal

6729

Ms. Bhavya

6730

Mr. Himanshu Sachdeva

6731

Ms. Alishah Raza

6732

Mr. Aryan Sharma

6733

Mr. Neeraj Kumar

6734

Ms. Smitika Mitra

6735

Ms. Afifa Akram

6736

Ms. Shreya Satija

6737

Mr. Sarthak Yadav

6738

Mr. Sanskar Gupta

6739

Mr. Tushar Dudeja

6740

Mr. Avinash Prasad Verma

6741

Ms. Oshien Gole

6742

Ms. Mansi Sharma

6743

Ms. Vidya

6744

Mr. Ilhan Ahmed Khan

6745

Ms. Priya Tanwar

6746

Ms. Priyanshi Sharma

6747

Mr. Laxit K Bhatt

6748

Ms. Akanksha Singh

6749

Ms. Simran Dixit

6750

Ms. Apoorvi Suri

6751

Ms. Jhalak Verma

6752

Ms. Shutkirti Bharti

6753

Mr. Gaurav Kr. Burman

6754

Mr. Ravindra P. Gupta

6755

Mr. Puru Tuteja

6756

Ms. Priyansha Bhatia

IPGA NEW MEMBERS

42

6757

Mr. Syed Ali H. Zaidi

6758

Mr. Raushan Kumar

6759

Mr. Dipesh Raj Singh

6760

Mr. Nikhil Kumar Pathak

6761

Mr. Subhash Chandra Giri

6762

Mr. Amriendra Kumar

6763

Mr. Deepak Kumar

6764

Ms. Chandni

6765

Mr. Divyanshu Raj

6766

Mr. Manish Kumar

6767

Mr. Nitish Kumar

6768

Mr. Ankit Kumar

6769

Mr. Mukul Kumar

6770

Mr. Rajan Kumar Paswan

6771

Mr. Ritesh Kumar

6772

Ms. Jaya Singh

6773

Ms. Gunjan Kumari

6774

Ms. Km Sarika

6775

Ms. Tanu Ranjan

6776

Dr. Narendra K. Nyola

6777

Dr. Mujeebur Rahman

6778

Dr. Suresh Choudhary

6779

Dr. Shivli Nomani

6780

Dr. Gazala Parveen

6781

Dr. Yogendra Singh

6782

Dr. William A. Sundar

6783

Dr. Jeyaram B. Jeyabalan

6784

Mr. Chandra K. Sharma

6785

Ms. Nidhi Verma

6786

Mr. Shailesh Kumar Singh

6787

Mr. Sahaj Chhabra

6788

Mr. Dhruv Sharma

6789

Ms. Jyoti

6790

Mr. Sandeep Chopra

6791

Ms. Asra Jabeen

6792

Mr. Abhinav Mittal

6793

Mr. Naman Kumar Gupta

6794

Mr. Rajesh Kumar

6795

Mr. Ramveer Singh Rana

6796

Mr. Himansu Chopra

6797

Mr. Sundeep K. Sharma

6798

Mr. Prabin Kumar Shahu

6799

Mr. Deepanshu Mishra

6800

Mr. Akshay Sachdeva

6801

Mr. Yashasvi Vaid

6802

Dr. Nagaraju Pappula

6803

Ms. Palak Jain

6804

Ms. Kawal Jeet Kaur

6805

Ms. Sreetama Moitra

6806

Ms. Puspita Roy

6807

Mr. Shovan Naskar

6808

Mr. Sattik Mallick

6809

Mr. Soumyadip Ghosh

6810

Mr. Souvik Sarkar

6811

Ms. Neha Biswas

6812

Ms. Saptami Goswami

Photographs of some of the new members couldn't be printed due to Due to Non Availability of High Resolution Photograph.

All such members are requested to forward soft copy of their photographs at pawankr52@gmail.com alongwith their Name and LM Number.

IPGA NEW MEMBERS

43

* Due to Non Availability of High Resolution Photograph, we could not print it. Kindly forward soft copy of photographs at delhiexp45@hotmail.com alongwith your Name and LM Number.

6813

Mr. Manu Singhai

6814

Ms. Ritu Saini

6815

Mr. Anas Saifi

6816

Mr. Sachin Ashok Kamble

6817

Mr. Vivek P. Khedkar

6818

Mr. Aniket Upla

6819

Mr. Mukesh Bhardwaj

6827

Ms. Navjit Kaur

6828

Ms. Gurminder Kaur

6829

Ms. Ritu Saini

6830

Ms. Chahanpreet Kaur

6831

Ms. Harpreet Kaur

6832

Ms. Ramandeep Kaur

6833

Mr. Tapan Kumar Mahto

6820

Mrs. Swrupa Arvapalli

6821

Mrs. Shyamala

6822

Mr. Vikas P. Singh

6823

Mr. Shiv K. Srivastava

6824

Dr. Ajay Singh Kushwah

6825

Dr. Rahul Kumar Sharma

6826

Mr. Satvir Singh

6834

Dr. Parimalakrishnan

6835

Mr. Anindya Banerjee

6836

Mr. Kasi S

6837

Dr. Satish Shrishail Karoli

6838

Dr. Limce Thampi

6839

Mr. Pardeep K. Suhag

6840

Dr. Gini E J

I promise to do all I can to protect and improve the physical and moral well-being of society, holding the health and safety of my community above other considerations. I shall uphold the laws and standards governing my profession avoiding all forms of misrepresentation and I shall safeguard the distribution of medical and potent substances.

Knowledge gained about patients I shall hold in confidence and never divulge unless compelled to do so by law.

I shall strive to perfect and enlarge my knowledge the better to contribute to the advancement of pharmacy and the public health.

I furthermore promise to maintain my honour and credit in all transactions and by my conduct never to bring discredit to myself or my profession nor to do anything to diminish the trust reposed in my professional brethern.

May I prosper and live long in favour as I keep and hold to this my oath but should I violate these sacred promises may the reverse by my lot.

To aid, assist & finance, establish and run, conduct conventions, scholarships, training, seminars, coaching, placements, consultancies, research projects, and such other activities as may be necessary for upliftment of members of Indian Pharmacy Graduates’ Association and for the general public welfare particularly of women, children, senior citizens and handicapped persons of all castes and creeds.

Mission

The IPGA Welfare Trust has decided to contribute a sum of Rs. 15000/- for IPGA Welfare Trust sponsored Conference/Seminar/Workshop* organised by an institute imparting degree course in pharmacy for the welfare of Pharmacy Graduates. ( For sponsorship write to the managing trustee : atulnasa@gmail.com with detailed proposal)

Anil Kr. Negi9310053001

negikranil@gmail.com

P.K. Jaggi9811168062

pk_jaggi@rediffmail.com

Bhanu Dua9811072757

glycoremedies@yahoo.com

Arun Garg 8470046553

agarg333@hotmail.com

S.L. Nasa9313294423

slnasa@yahoo.co.in

P.P. Sharma9871471515

mail.ppsharma@gmail.com

Atul Kr. Nasa9871318288

atulnasa@gmail.com

S.L. Sobti9811042169

slsobti@gmail.com

Trustees

RECENT SPONSORSHIPS BY IPGA WELFARE TRUST

Opinions expressed in IPGA TODAY are those of the authors and do not necessarily reflect the views of Indian Pharmacy Graduates’ Association.All rights reserved. Material from IPGA TODAY may be reproduced without written permission provided the source is acknowledged.

Regd. Off. : F-2, A-Block, DDA Shopping Complex, Meera Bagh, New Delhi-110087, India

Have you moved ?If your correspondence address has changed, please forward your new address to IPGA-TODAY.

Edited and Published by : Mr. P.K. Jaggi, on behalf of the Indian Pharmacy Graduates’ Association, F-2, A-Block, DDA Shopping Complex, Meera Bagh, New Delhi-110087, India

IPGA WELFARE TRUST Established : March 2009

Bharat Bhushan9810777569

bharat47_2005@yahoo.com

Vijay Bhalla9810540434

vijay_0434@hotmail.com

44

(Rupees)

Managing TrusteeManaging TrusteeManaging Trustee

4. SANKHA BHATTACHARYA (STUDENT), B.C.D.A. COLLEGE OF PHARMACY, WEST BENGAL 25000 08/03/2020

1. ASBASJSM COLLEGE OF PHARMACY, BELA 25000 08/03/2020

2. SGT COLLEGE OF PHARMACY, GURUGRAM 25000 08/03/2020

3. SAT KAIVAL COLLEGE OF PHARMACY, SARSA, GUJARAT 25000 08/03/2020

S.No. Name of The Institution Amount Approved

in RupeesDate of

Approval